Wave Life Sciences, Inc. (WVE) stock
WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3039% below fair value
$3.13−0.02 (-0.79%)
Close on Nov 13, 2026Market cap $617.33MP/E –Yield –
Wave Life Sciences statistics
78 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.54
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 2.63
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 20.2%
- 10.8%
- Shares Change (QoQ)
- 2.04%
- 0.50%
- Float
- 152M
- 49M
- Shares Held by Insiders
- 23.1%
- 11.7%
- Shares Held by Institutions
- 92.6%
- 56.4%
Short sellingIndustry
- Short Interest
- 21M
- –
- Short Interest Change
- -2.45%
- -0.80%
- Short % of Float
- 13.6%
- 9.01%
- Short % of Shares Outstanding
- 10.5%
- 6.30%
- Days to Cover
- 6.76
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $21.73
- –
- 52-Week Low
- $3.00
- –
- 20-Day Moving Average
- $3.40
- –
- 50-Day Moving Average
- $3.73
- –
- 200-Day Moving Average
- $6.92
- –
- Average True Range (14)
- $0.24
- –
- Price Change (1 Week)
- -6.98%
- -1.15%
- Price Change (1 Month)
- -1.88%
- -4.87%
- Price Change (3 Months)
- -38.5%
- -21.0%
- Price Change (6 Months)
- -53.8%
- -20.6%
- Price Change (YTD)
- -81.6%
- -23.6%
- Price Change (1 Year)
- -55.0%
- -22.4%
- Price Change (3 Years)
- -42.5%
- -29.5%
- Price Change (5 Years)
- -32.8%
- -77.9%
- Price Change (10 Years)
- -91.6%
- -65.4%
- Average Volume (10 Days)
- 3M
- –
- Average Volume (20 Days)
- 3M
- –
- Average Volume (90 Days)
- 3M
- –
- Relative Volume
- 0.87
- 0.70
- Relative Strength Index (14)
- 37.7
- 43.4
- Volatility (1 Year)
- 167.5%
- 80.1%
- Beta (5 Years)
- 1.30
- 1.07
MarginsIndustry
- Pretax Margin
- -296.9%
- -11.6%
- EBITDA Margin
- -320.9%
- -27.7%
- FCF Margin
- -293.8%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -80.0%
- -49.9%
- Return on Assets (ROA)
- -56.2%
- -40.6%
- Return on Capital Employed (ROCE)
- -50.2%
- -37.9%
Financial positionIndustry
- Current Ratio
- 8.38
- 3.30
- Quick Ratio
- 8.09
- 2.39
GrowthIndustry
- Revenue Growth (3Y CAGR)
- 127.1%
- 2.25%
- Revenue Growth (5Y CAGR)
- 16.3%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.19
- 0.40
- Revenue Per Employee
- $223.73K
- $429.29K
- Profits Per Employee
- -$664.14K
- -$689.41K
- Employee Count
- 317
- 74
- WACC
- 11.6%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$210.53M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $431.00M
- $17.76M
- Net Cash Per Share
- $2.19
- $0.80
- Equity (Book Value)
- $401.94M
- $53.89M
- Book Value Per Share
- $2.04
- $1.50
- Tangible Book Value
- $401.94M
- $27.13M
- Working Capital
- $403.87M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$1.34M
- -$1.00M
- FCF Per Share
- -$1.06
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -34.1%
- -21.8%
- FCF Yield
- -33.8%
- -9.44%
Taxes and interestIndustry
- Income Tax
- $0
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- -0.98
- 0.23
- Piotroski F-Score
- 3
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | WVE | S&P 500 | Difference | WVE per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -0.3% | -3.0% | +2.7 pts | ||
| 3 months | -39.8% | -2.8% | −37.0 pts | ||
| Year to date | -81.6% | +11.5% | −93.1 pts | ||
| 1 year | -53.1% | +13.5% | −66.5 pts | ||
| 3 years | -39.7% | +77.7% | −117.4 pts | -15.5% | +21.1% |
| 5 years | -32.8% | +72.6% | −105.4 pts | -7.7% | +11.5% |
| 10 years | -91.4% | +308.2% | −399.6 pts | -21.8% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
21M WVE shares were sold short on Oct 30, 2026, down 2.4% from the previous report, or 13.61% of the shares available to trade. At recent volumes it would take 6.8 days to buy them back. Over the last 20 sessions, 44.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 20,649,846 | -2.4% | 3,056,842 | 6.8 |
| Oct 15, 2026 | 21,167,722 | +14.1% | 3,242,681 | 6.5 |
| Sep 30, 2026 | 18,556,315 | +5.2% | 3,255,781 | 5.7 |
| Sep 15, 2026 | 17,637,783 | +8.3% | 3,414,003 | 5.2 |
| Aug 31, 2026 | 16,281,873 | +0.5% | 2,964,270 | 5.5 |
| Aug 14, 2026 | 16,200,874 | -1.2% | 3,689,771 | 4.4 |
| Jul 31, 2026 | 16,401,737 | -2.7% | 2,200,935 | 7.5 |
| Jul 15, 2026 | 16,848,760 | -19.4% | 2,674,732 | 6.3 |
| Jun 30, 2026 | 20,901,285 | +15.1% | 3,678,558 | 5.7 |
| Jun 15, 2026 | 18,153,025 | -2.0% | 3,250,978 | 5.6 |
| May 29, 2026 | 18,530,652 | +4.3% | 4,053,792 | 4.6 |
| May 15, 2026 | 17,770,733 | +6.3% | 4,281,323 | 4.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?